OBJECTIVE: To examine the relationship between cancer stage, surgical treatment and chemotherapy on quality of life (QOL) after breast cancer and determine if sociodemographic characteristics modify the observed relationships. METHODS: A population-based sample of women with Stages 0-II breast cancer in the United States (N = 1357) completed surveys including the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), and the Breast Cancer-Specific Quality of Life Questionnaire (QLQ BR-23). Regression models calculated mean QOL scores across primary surgical treatment and chemotherapy. Clinically significant differences in QOL were defined as > or = 10 point difference (out of 100) between groups. RESULTS: Meaningful differences in QOL by surgical treatment were limited to body image with women receiving mastectomy with reconstruction reporting lower scores than women receiving breast conserving surgery (p < 0.001). Chemotherapy lowered QOL scores overall across four QOL dimensions (p values < 0.001), with a disproportionately greater impact on those with lower levels of education. Younger women reported lower QOL scores for seven of nine QOL dimensions (p values < 0.001). CONCLUSIONS: Women should be reassured that few QOL differences exist based on surgical treatment, however, clinicians should recognize that the impact of treatment on QOL does vary by a woman's age and educational level.
OBJECTIVE: To examine the relationship between cancer stage, surgical treatment and chemotherapy on quality of life (QOL) after breast cancer and determine if sociodemographic characteristics modify the observed relationships. METHODS: A population-based sample of women with Stages 0-II breast cancer in the United States (N = 1357) completed surveys including the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), and the Breast Cancer-Specific Quality of Life Questionnaire (QLQ BR-23). Regression models calculated mean QOL scores across primary surgical treatment and chemotherapy. Clinically significant differences in QOL were defined as > or = 10 point difference (out of 100) between groups. RESULTS: Meaningful differences in QOL by surgical treatment were limited to body image with women receiving mastectomy with reconstruction reporting lower scores than women receiving breast conserving surgery (p < 0.001). Chemotherapy lowered QOL scores overall across four QOL dimensions (p values < 0.001), with a disproportionately greater impact on those with lower levels of education. Younger women reported lower QOL scores for seven of nine QOL dimensions (p values < 0.001). CONCLUSIONS:Women should be reassured that few QOL differences exist based on surgical treatment, however, clinicians should recognize that the impact of treatment on QOL does vary by a woman's age and educational level.
Authors: M Amichetti; O Caffo; M Arcicasa; M Roncadin; O Lora; A Rigon; G Zini; L Armaroli; F Coghetto; P Zorat; S Neri; N Teodorani Journal: Breast Cancer Res Treat Date: 1999-03 Impact factor: 4.872
Authors: L B Wenzel; D L Fairclough; M J Brady; D Cella; K M Garrett; B C Kluhsman; L A Crane; A C Marcus Journal: Cancer Date: 1999-11-01 Impact factor: 6.860
Authors: M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson Journal: J Clin Oncol Date: 1996-10 Impact factor: 44.544
Authors: Maria Papaleontiou; David Reyes-Gastelum; Brittany L Gay; Kevin C Ward; Ann S Hamilton; Sarah T Hawley; Megan R Haymart Journal: Thyroid Date: 2019-07-25 Impact factor: 6.568
Authors: Nancy K Janz; Sarah T Hawley; Mahasin S Mujahid; Jennifer J Griggs; Amy Alderman; Ann S Hamilton; John J Graff; Reshma Jagsi; Steven J Katz Journal: Cancer Date: 2011-03-28 Impact factor: 6.860
Authors: Karen Kadela Collins; Ying Liu; Mario Schootman; Rebecca Aft; Yan Yan; Grace Dean; Mark Eilers; Donna B Jeffe Journal: Breast Cancer Res Treat Date: 2010-08-05 Impact factor: 4.872
Authors: Shoshana M Rosenberg; Michaela S Tracy; Meghan E Meyer; Karen Sepucha; Shari Gelber; Judi Hirshfield-Bartek; Susan Troyan; Monica Morrow; Lidia Schapira; Steven E Come; Eric P Winer; Ann H Partridge Journal: Ann Intern Med Date: 2013-09-17 Impact factor: 25.391
Authors: Shi-Yi Wang; Sylvia H Hsu; Cary P Gross; Tara Sanft; Amy J Davidoff; Xiaomei Ma; James B Yu Journal: Value Health Date: 2016-04-07 Impact factor: 5.725
Authors: Sarah T Hawley; Nancy K Janz; Ann Hamilton; Jennifer J Griggs; Amy K Alderman; Mahasin Mujahid; Steven J Katz Journal: Patient Educ Couns Date: 2008-11
Authors: Nancy K Janz; Mahasin S Mujahid; Sarah T Hawley; Jennifer J Griggs; Amy Alderman; Ann S Hamilton; John Graff; Steven J Katz Journal: J Cancer Surviv Date: 2009-09-16 Impact factor: 4.442
Authors: Alix G Sleight; Kathleen Doyle Lyons; Cheryl Vigen; Heather Macdonald; Florence Clark Journal: Support Care Cancer Date: 2018-05-16 Impact factor: 3.603